NASDAQ:XWEL

XWELL (XWEL) Stock Forecast, Price & News

$0.26

-0.01 (-3.70%)

(As of 06/9/2023 ET)

Compare

Today's Range: $0.26
▼
$0.28
50-Day Range: $0.23
▼
$0.34
52-Week Range: $0.22
▼
$1.20

Volume: 99,319 shs
Average Volume: 156,425 shs
Market Capitalization: $21.69 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $1.00

XWELL MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 284.6% Upside
$1.00 Price Target
Short Interest: Bearish
1.79% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$12,500 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.01 out of 5 stars

Medical Sector

779th out of 987 stocks

Personal Services Industry

11th out of 13 stocks

3.5

Analyst's Opinion

Consensus Rating
XWELL has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $1.00, XWELL has a forecasted upside of 284.6% from its current price of $0.26.
Amount of Analyst Coverage
XWELL has only been the subject of 1 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
1.79% of the float of XWELL has been sold short.
Short Interest Ratio / Days to Cover
XWELL has a short interest ratio ("days to cover") of 8.
Change versus previous month

0.0

Dividend Strength

Dividend Yield
XWELL does not currently pay a dividend.
Dividend Growth
XWELL does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for XWEL.

2.7

News and Social Media Coverage

News Sentiment
XWELL has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for XWELL this week, compared to 2 articles on an average week.
Search Interest
Only 1 people have searched for XWEL on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added XWELL to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, XWELL insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,500.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 2.30% of the stock of XWELL is held by insiders.
Percentage Held by Institutions
Only 10.85% of the stock of XWELL is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of XWELL is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of XWELL is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
XWELL has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About XWELL (NASDAQ:XWEL) Stock

XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Treat, and Corporate and Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment consists of access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.

Receive XWEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XWELL and its competitors with MarketBeat's FREE daily newsletter.

XWEL Stock News Headlines

May 20, 2023 | americanbankingnews.com

Q2 2023 Earnings Estimate for XWELL, Inc. Issued By HC Wainwright (NASDAQ:XWEL)

May 16, 2023 | finance.yahoo.com

Q1 2023 XWELL Inc Earnings Call

June 10, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

May 15, 2023 | finance.yahoo.com

XWELL, Inc. Reports First Quarter 2023 Results

May 11, 2023 | marketwatch.com

Global Spot Welding Machine For Lithium Battery Market Size 2023-2031 Business Strategies by Absolute Reports | with [101 Pages]

May 11, 2023 | finance.yahoo.com

XWELL, Inc. to Announce First Quarter 2023 Financial Results on Monday, May 15

May 4, 2023 | finance.yahoo.com

XWELL, Inc. Names Valerie Lightfoot Chief Financial Officer

May 3, 2023 | finance.yahoo.com

XWELL Unveils Automated Massage Chairs at XpresSpa Locations Across the U.S.

June 10, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

May 3, 2023 | americanbankingnews.com

Rover Group (NASDAQ:ROVR) versus XWELL (NASDAQ:XWEL) Head to Head Contrast

April 27, 2023 | finance.yahoo.com

XWELL, Inc. Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule

April 19, 2023 | marketwatch.com

Xwell 2022 Revenue Drops Amid Covid-19 Testing Site Closures

April 19, 2023 | finance.yahoo.com

Revenues Working Against XWELL, Inc.'s (NASDAQ:XWEL) Share Price

April 18, 2023 | msn.com

HC Wainwright & Co. Reiterates XWELL (XWEL) Buy Recommendation

April 18, 2023 | benzinga.com

XWELL shares are trading lower after the company reported FY22 financial results.

April 18, 2023 | benzinga.com

XWELL Earnings Perspective: Return On Capital Employed

April 18, 2023 | markets.businessinsider.com

Analysts Offer Insights on Services Companies: XWELL (XWEL) and Vertex Energy (VTNR)

April 18, 2023 | finance.yahoo.com

Q4 2022 XWELL Inc Earnings Call

April 17, 2023 | finance.yahoo.com

XWELL, Inc. Reports Fiscal Year 2022 Results

April 14, 2023 | finance.yahoo.com

XWELL, Inc. to Announce 2022 Financial Results on Monday April 17

April 12, 2023 | americanbankingnews.com

Critical Contrast: XWELL (NASDAQ:XWEL) vs. CVS Group (OTCMKTS:CVSGF)

April 8, 2023 | americanbankingnews.com

Q1 2023 EPS Estimates for XWELL, Inc. (NASDAQ:XWEL) Increased by HC Wainwright

April 6, 2023 | marketwatch.com

2023-2030 Battery Cell Charge and Discharge Tester Market Size and Recent Developments | Research Report by Absolute Reports

April 4, 2023 | markets.businessinsider.com

XWELL (XWEL) Receives a Buy from H.C. Wainwright

April 4, 2023 | americanbankingnews.com

HC Wainwright Lowers XWELL (NASDAQ:XWEL) Price Target to $1.00

March 30, 2023 | finance.yahoo.com

XWELL Announces Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K And Provides Preliminary FY2022 Operating Update

March 30, 2023 | americanbankingnews.com

Contrasting Cannabis Sativa (OTCMKTS:CBDS) and XWELL (NASDAQ:XWEL)

See More Headlines

XWEL Price History

30 days | 90 days | 365 days | Advanced Chart

XWEL Company Calendar

Last Earnings: 4/17/2023
Today: 6/10/2023
Next Earnings (Estimated): 8/21/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Personal services
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:XWEL
CUSIP: N/A
CIK: 1410428
Web: www.xwell.com
Phone: (212) 750-9595
Fax: 309-410-3967
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $1.00
High Stock Price Forecast: $1.00
Low Stock Price Forecast: $1.00
Forecasted Upside/Downside: +284.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.38)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-32,840,000.00
Net Margins: -87.44%
Pretax Margin: -91.50%
Return on Equity: -58.73%
Return on Assets: -42.66%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.41
Quick Ratio: 4.30

Sales & Book Value

Annual Sales: $55.94 million
Price / Sales: 0.39
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.51 per share
Price / Book: 0.51

Miscellaneous

Outstanding Shares: 83,420,000
Free Float: 81,500,000
Market Cap: $21.69 million
Optionable: Optionable
Beta: 2.01

Key Executives

Scott R. Milford
President, Chief Executive Officer & Director

Omar A. Haynes
Chief Financial Officer

David Kohel
Chief Technology Officer

Cara Soffer
Senior Vice President & General Counsel

Tesh Ramsarup
Director-Operation Services

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

XWEL Stock - Frequently Asked Questions

Should I buy or sell XWELL stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for XWELL in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" XWEL shares.
View XWEL analyst ratings or view top-rated stocks.
What is XWELL's stock price forecast for 2023?: 1 analysts have issued 12 month target prices for XWELL's stock. Their XWEL share price forecasts range from $1.00 to $1.00. On average, they expect the company's share price to reach $1.00 in the next year. This suggests a possible upside of 284.6% from the stock's current price.
View analysts price targets for XWEL or view top-rated stocks among Wall Street analysts.
How have XWEL shares performed in 2023?: XWELL's stock was trading at $0.3629 at the start of the year. Since then, XWEL shares have decreased by 28.4% and is now trading at $0.26.
View the best growth stocks for 2023 here.
When is XWELL's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our XWEL earnings forecast.
How were XWELL's earnings last quarter?: XWELL, Inc. (NASDAQ:XWEL) announced its earnings results on Monday, April, 17th. The company reported ($0.15) earnings per share for the quarter. The company had revenue of $7.56 million for the quarter. XWELL had a negative trailing twelve-month return on equity of 58.73% and a negative net margin of 87.44%.

What is XWELL's stock symbol?: XWELL trades on the NASDAQ under the ticker symbol "XWEL."
Who are XWELL's major shareholders?: XWELL's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (2.22%), Geode Capital Management LLC (1.25%), Integrated Wealth Concepts LLC (0.25%), Bank of New York Mellon Corp (0.11%) and Group One Trading L.P. (0.00%). Insiders that own company stock include Bruce Bernstein, Robert Weinstein and Scott R Milford.
View institutional ownership trends.
How do I buy shares of XWELL?: Shares of XWEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is XWELL's stock price today?: One share of XWEL stock can currently be purchased for approximately $0.26.
How much money does XWELL make?: XWELL (NASDAQ:XWEL) has a market capitalization of $21.69 million and generates $55.94 million in revenue each year. The company earns $-32,840,000.00 in net income (profit) each year or ($0.38) on an earnings per share basis.
How can I contact XWELL?: XWELL's mailing address is 254 WEST 31ST STREET 11TH FLOOR, NEW YORK NY, 10001. The official website for the company is www.xwell.com. The company can be reached via phone at (212) 750-9595, via email at ir@xpresspagroup.com, or via fax at 309-410-3967.

This page (NASDAQ:XWEL) was last updated on 6/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial